These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7289887)

  • 41. Megestrol acetate therapy for advanced breast cancer.
    Gregory EJ; Cohen SC; Oines DW; Mims CH
    J Clin Oncol; 1985 Feb; 3(2):155-60. PubMed ID: 3838187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of megestrol acetate in advanced breast cancer on a single-daily-dose schedule.
    Carpenter JT; Peterson L
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):40-2. PubMed ID: 3975651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relation of physiological changes to subjective symptoms in postmenopausal women with and without hot flushes.
    Mashchak CA; Kletzky OA; Artal R; Mishell DR
    Maturitas; 1984 Dec; 6(4):301-8. PubMed ID: 6533433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
    Cruz JM; Muss HB; Russell G
    Oncology; 1992; 49 Suppl 2():8-11. PubMed ID: 1461630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-dependent response of FSH, flushes and urinary calcium to oestrogen.
    Jones MM; Pearlman B; Marshall DH; Crilly RG; Nordin BE
    Maturitas; 1982 Dec; 4(4):285-90. PubMed ID: 6820470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased urinary calcium loss and lower bone turnover in young oral contraceptive users.
    Zittermann A
    Metabolism; 2000 Aug; 49(8):1078-82. PubMed ID: 10954029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of megestrol acetate on the endometrium of the prepubertally ovariectomised kitten.
    Bellenger CR; Chen JC
    Res Vet Sci; 1990 Jan; 48(1):112-8. PubMed ID: 2300703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
    Goodwin JW; Green SJ; Moinpour CM; Bearden JD; Giguere JK; Jiang CS; Lippman SM; Martino S; Albain KS
    J Clin Oncol; 2008 Apr; 26(10):1650-6. PubMed ID: 18375894
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.
    Muss HB; Case LD; Capizzi RL; Cooper MR; Cruz J; Jackson D; Richards F; Powell BL; Spurr CL; White D
    J Clin Oncol; 1990 Nov; 8(11):1797-805. PubMed ID: 2230868
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seasonal variations in indices of bone formation precede appropriate bone mineral changes in normal men.
    Hyldstrup L; McNair P; Jensen GF; Transbøl I
    Bone; 1986; 7(3):167-70. PubMed ID: 3768193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of dose and timing of calcium supplementation on bone resorption in early menopausal women.
    Scopacasa F; Need AG; Horowitz M; Wishart JM; Morris HA; Nordin BE
    Horm Metab Res; 2002 Jan; 34(1):44-7. PubMed ID: 11833002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of megestrol acetate on interleukin-1 activity.
    Terada K; Suthum PA; Katsura K; Hokama Y
    Gynecol Oncol; 1991 Dec; 43(3):260-1. PubMed ID: 1752496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
    Vural P; Akgul C; Canbaz M
    Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
    Cobau CD; Declercq K; Neuberg D; Ingle JN; Tormey DC
    Cancer; 1996 Feb; 77(3):483-9. PubMed ID: 8630955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer.
    Foitl DR; Hyman G; Lefkowitch JH
    Cancer; 1989 Feb; 63(3):438-9. PubMed ID: 2912522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of injection of microencapsulated compound megestrol acetate on the ultrastructure of the adenohypophysis].
    Chen WY; Ou KQ; Liu HM; Yu J; Han ZY
    Hua Xi Yi Ke Da Xue Xue Bao; 1987 Sep; 18(3):222-5. PubMed ID: 3679171
    [No Abstract]   [Full Text] [Related]  

  • 57. Familial hypocalciuric hypercalcaemia. III: Bone mineral metabolism.
    Kristiansen JH; Rødbro P; Christiansen C; Johansen J; Jensen JT
    Clin Endocrinol (Oxf); 1987 Jun; 26(6):713-6. PubMed ID: 3665125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship between oestrogen status and bone loss in post-menopausal women.
    Nordin BE; Horsman A; Brook R; Williams DA
    Clin Endocrinol (Oxf); 1976; 5 Suppl():353S-361S. PubMed ID: 1052784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Relationship between bone mineral density and blood and urine biochemical indices in women].
    Hu Y; Zhao X; Bai J
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Sep; 33(5):298-300. PubMed ID: 11864497
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
    Farish E; Barnes JF; Rankin M; Hart DM
    Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.